During the past decade, Commissione Genetica Lega Italiana contro l'Epilepssia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Commissione Genetica Lega Italiana contro l'Epilepssia" #1 collaborator was "Cardiff University" with 2 trials as a collaborator, "King's College Hospital NHS Trust" with 2 trials as a collaborator, "The Hospital for Sick Children" with 2 trials as a collaborator, "Aghia Sophia Children's Hospital of Athens" with 1 trials as a collaborator and "Charles University, Czech Republic" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Commissione Genetica Lega Italiana contro l'Epilepssia" are "Juvenile Myoclonic Epilepsy" (1 trials) and "Rolandic Epilepsy" (1 trials). Many other conditions were trialed in "Commissione Genetica Lega Italiana contro l'Epilepssia" in a lesser frequency.

Most popular intervention types in "Commissione Genetica Lega Italiana contro l'Epilepssia" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Blood draw" (2 trials) and "Existing samples" (2 trials). Other intervention names were less common.

The vast majority of trials in "Commissione Genetica Lega Italiana contro l'Epilepssia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Commissione Genetica Lega Italiana contro l'Epilepssia". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Commissione Genetica Lega Italiana contro l'Epilepssia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Commissione Genetica Lega Italiana contro l'Epilepssia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".